news & events

Check out what we’ve been up to and where can we connect!


Baricitinib + remdesivir superior to remdesivir alone for hospitalized adults with COVID-19: ACTT-2 results published in NEJM

April 24, 2021
Results of the Adaptive COVID-19 Treatment Trial (ACTT)-2 investigating combination treatment with baricitinib, a Janus kinase inhibitor, and remdesivir for the treatment of COVID-19 in hospitalized adults were published in the New England Journal of Medicine (NEJM) on March 4, 2021, showing that the combination treatment was superior to remdesivir alone.

Read More »


ASTMH 2021 Annual Meeting

November 17-21, 2021
Attending the ASTMH 2021 Annual Meeting? Schedule a meeting with an FHI Clinical team member who will be in attendance at the event or stop by one of our poster presentations.

Read More »

Are CROs prepared for ICH E6 (R3)?

September 27, 2021
In this webcast we will explore the intended purpose of ICH regulations; what organizations stand to gain from adopting the updated guidelines; how organizations can improve their operational efficiencies by minimizing duplicate quality-assurance steps; strategies for quick, relatively straightforward adoption of the new guidelines.

Read More »